BioSpectrumIndia - the business of biotech

HOME

SITEMAP

FEEDBACK

ARCHIVES

MEDIA KIT

Search:

Help

BIOSPECTRUM INDIA LIFE SCIENCES RESOURCE GUIDE 2008

Download the Questionnaire
The directory to be launched in June 2008 at BIO San Diego, USA.
Last date to receive the filled form is April 20, 2008

COVER STORY

India boosts CRAMS sector

MNCs will outsource more pharma production to India”
Rajesh Jain, Joint Managing Director, Panacea Biotec.

BIOSPECIAL

The Nobel Prize in Biology, 1982-2007

BIOPOLICY

A lease of life to GM crops
The recent SC order on the lifting of the ban on GM crops has large implications for the farming community, most notably the bioagri companies

BIOCOLUMN
Cross-border investments, a win-win proposition Mark Ravera, principal at US-based Strategic Pharma Consulting Group
The drying pipeline Dr KK Narayanan, managing director, Metahelix Life Sciences
Contribute to the future of humanity Dr Edison T Liu, executive director of the Genome Institute of Singapore.

BIOTALK
“We’ve plans to open Thailand and Malaysia chapters” Thomas Adams, President & CEO, Association of Clinical Research Professionals (ACRP)

BIORESEARCH

"Fluorescents are replacing traditional dyes in protein detection assays,” Dr Duncan Veal, CEO, Flourotechnics, Australia
BIOSUPPLIERS
IR, UV-VIS instruments in India The combined UV/VIS market in India is $16 million.
“Thermo Fisher Scientific continues to invest substantially in R&D spending globally,” Amit Chopra, MD, Laboratory Products for Thermo Fisher.
Lab India enjoys a formidable share in the mass spectrometry business,” Umesh Pawa, VP, PSM division, Labindia Instruments Pvt Ltd

BIOBUSINESS
Incubators accelerate entrepreneurial spirit -India is expected to have more than 20 biotech incubators by 2010. This will help start-ups to focus on their core activities.
FDA approvals for biotechs decline -The US FDA approvals for biopharma products plunged in 2007.
Umbilical cord stem cell banking bandwagon swells -With over 26 million births being registered every year in India, the number of Stem cell banking companies in India is on the rise.
We would be getting into public banking shortly,” -Abhaya Kumar, Vice-Chairman LifeCell
We are the only Indian company to have banking facilities abroad -Dr. C V Nerikar, CEO, Cryobank International India
Europe Calling for Siro Clinpharm -In tune with its globalization plans, Siro Clinpharm is now looking at exploring European markets.
We are trying to emerge as an Indian MNC CRO -Dr Chetan Tamhankar, COO, Siro Clinpharm Pvt Ltd
RFCL on an acquisition spree
We expect to reach a revenue target of Rs 500 crore by 2010 -Sushil Mehta, managing director, RFCL
Satyam steps up focus on life sciences -Satyam’s recent foray into the life sciences segment can prove to be a significant differentiator for it in the market.

Current Issue

Read Testimonials

EDITORIAL

Biotech losing steam?

BIONEWS

	Avesthagen starts Phase III trials of 3 bioactives
more >>

About BioSpectrum | Feedback | Contact Us

Copyright © CyberMedia All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.
Usage of this web site is subject to terms and conditions.

Broken links? Problem with site? Send email to webmaster@cybermedia.co.in